Reckitt Benckiser Group (Reckitt Benckiser Group) Long-Term Capital Lease Obligation : $315 Mil (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Reckitt Benckiser Group Long-Term Capital Lease Obligation?

Reckitt Benckiser Group's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $315 Mil.

Reckitt Benckiser Group's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 ($379 Mil) to Jun. 2023 ($340 Mil) and declined from Jun. 2023 ($340 Mil) to Dec. 2023 ($315 Mil).

Reckitt Benckiser Group's annual Long-Term Capital Lease Obligation increased from Dec. 2021 ($354 Mil) to Dec. 2022 ($379 Mil) but then declined from Dec. 2022 ($379 Mil) to Dec. 2023 ($315 Mil).

Reckitt Benckiser Group Long-Term Capital Lease Obligation Historical Data

The historical data trend for Reckitt Benckiser Group's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reckitt Benckiser Group Long-Term Capital Lease Obligation Chart

Reckitt Benckiser Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

331.59

323.93

353.72

378.81

315.19

Reckitt Benckiser Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															353.72	331.28	378.81	339.65	315.19

Reckitt Benckiser Group (OTCPK:RBGPF) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Reckitt Benckiser Group Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Reckitt Benckiser Group's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Reckitt Benckiser Group (Reckitt Benckiser Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Reckitt Benckiser Group PLC (OTCPK:RBGPF) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

RBGLY:USA RB:Mexico RKTl:UK RKT:UK 3RB:Germany

Address

103-105 Bath Road, Slough, Berkshire, GBR, SL1 3UH

Website

https://www.reckitt.com

Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.